mongersen (GED-0301) - BMS
Celgene: J.P. Morgan Healthcare Conference (35th Annual J.P. Morgan Healthcare Conference, Celgene) - Jan 11, 2017 - Anticipated launch for Crohn's disease in 2019; Anticipated approval for inflammatory bowel diseases in 2019 
Anticipated launch • Anticipated regulatory Inflammatory Bowel Disease
http://files.shareholder.com/downloads/AMDA-262QUJ/3347272039x0x923371/4430516D-0819-404C-9585-8366ABB74CC2/Celgene_JPM_FINAL_-_For_Distribution.pdf
 
Jan 11, 2017
 
 
9d39a1e1-db1b-49e3-96d5-aabf03cbfef5.jpg

5801df88-4630-4056-b373-6935ba9ea67a.jpg